{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T11:43:26Z","timestamp":1787917406060,"version":"build-2784847793"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Schistosomiasis is one of the most overlooked parasitic diseases worldwide. The new roadmap for neglected tropical diseases (2021-2030), adopted by the World Health Assembly, sets global goals for combating these diseases. eliminating schistosomiasis. Current treatment options for schistosomiasis, such as Praziquantel, are limited. Nanoparticle-based treatments and vaccines have shown promise in overcoming the limitations of Praziquantel therapy by offering targeted and sustained drug delivery. We advocate prioritizing and enhancing funding and collaboration for nanoparticle research targeting schistosomiasis. By investing in these innovative solutions in regions most impacted by schistosomiasis, we have the potential to alleviate the treatment burden and enhance patient adherence. This review paper explores anotechnological solutions, current trends, and long-term outcomes.<\/jats:p>","DOI":"10.4103\/jvbd.jvbd_180_23","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:01:30Z","timestamp":1752584490000},"page":"16-26","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Expanding the frontiers of schistosomiasis treatment: The promise of nanoparticle-based therapies"],"prefix":"10.4103","volume":"63","author":[{"given":"Gudibanda Nagaraja","family":"Bhuvana","sequence":"first","affiliation":[{"name":"Sri Sathya Sai University for Human Excellence, Kalaburagi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Mahima","family":"Umesh","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai University for Human Excellence, Kalaburagi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Raghavan","sequence":"additional","affiliation":[{"name":"Sri Sathya Sai University for Human Excellence, Kalaburagi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"12","key":"R1-20260302","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00436-023-07993-2","article-title":"Human schistosomiasis in Nigeria: present status, diagnosis, chemotherapy, and herbal medicines","volume":"122","author":"Saidu","year":"2023","journal-title":"Parasitol Res"},{"issue":"6","key":"R2-20260302","doi-asserted-by":"crossref","first-page":"40717","DOI":"10.1093\/trstmh\/trac134","article-title":"A literature review of schistosomiasis in Ghana: a reference for bridging the research and control gap","volume":"117","author":"Boateng","year":"2023","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"R3-20260302","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0972-9062.321759","article-title":"Vector-Borne diseases in Egypt: Present status and accelerating toward elimination","volume":"59","author":"Eassa","year":"2022","journal-title":"J Vector Borne Dis"},{"issue":"1","key":"R4-20260302","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0972-9062.313971","article-title":"A survey of urinary schistosomiasis among school aged children of ten communities in South-South, Nigeria","volume":"58","author":"Boih","year":"2021","journal-title":"J Vector Borne Dis"},{"issue":"1","key":"R5-20260302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-021-00919-z","article-title":"The economic impact of schistosomiasis","volume":"10","author":"Rinaldo","year":"2021","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"R6-20260302","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0001-706X(00)00122-4","article-title":"The global status of schistosomiasis and its control","volume":"77","author":"Chitsulo","year":"2000","journal-title":"Acta Trop"},{"issue":"2","key":"R7-20260302","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","article-title":"The Global epidemiological situation of schistosomiasis and new approaches to control and research","volume":"82","author":"Engels","year":"2002","journal-title":"Acta Trop"},{"key":"R8-20260302","doi-asserted-by":"crossref","first-page":"1013354","DOI":"10.3389\/fbioe.2022.1013354","article-title":"Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis","volume":"10","author":"Qadeer","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"R9-20260302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-020-04346-1","article-title":"Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni","volume":"13","author":"Eissa","year":"2020","journal-title":"Parasit Vectors"},{"issue":"3","key":"R10-20260302","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1166\/jbn.2018.2517","article-title":"Diagnosis, monitoring, and control of schistosomiasis-An update","volume":"14","author":"Wu","year":"2018","journal-title":"J Biomed Nanotechnol"},{"issue":"7","key":"R11-20260302","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/20477724.2022.2145070","article-title":"Praziquantel efficacy, urinary and intestinal schistosomiasis reinfection - A systematic review","volume":"117","author":"Aboagye","year":"2023","journal-title":"Pathog Glob Health"},{"issue":"6","key":"R12-20260302","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4155\/fmc.15.9","article-title":"Something old, something new: is praziquantel enough for schistosomiasis control?","volume":"7","author":"Secor","year":"2015","journal-title":"Future Med Chem"},{"issue":"5","key":"R13-20260302","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1021\/acsinfecdis.3c00081","article-title":"Perspective on schistosomiasis drug discovery: Highlights from a schistosomiasis drug discovery workshop at Wellcome collection, London, September 2022","volume":"9","author":"Caldwell","year":"2023","journal-title":"ACS Infect Dis"},{"issue":"10","key":"R14-20260302","doi-asserted-by":"crossref","first-page":"e1414","DOI":"10.1016\/S2214-109X(19)30346-8","article-title":"Improving public health control of schistosomiasis with a modified WHO strategy: a model-based comparison study","volume":"7","author":"Li","year":"2019","journal-title":"Lancet Glob Health"},{"issue":"12","key":"R15-20260302","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.pt.2023.09.006","article-title":"Defining schistosomiasis hotspots based on literature and shareholder interviews","volume":"39","author":"Lim","year":"2023","journal-title":"Trends Parasitol"},{"key":"R17-20260302","doi-asserted-by":"crossref","first-page":"98395","DOI":"10.2147\/IJGM.S391017","article-title":"Advances in diagnosis of schistosomiasis: Focus on challenges and future approaches","volume":"16","author":"Chala","year":"2023","journal-title":"Int J Gen Med"},{"key":"R18-20260302","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijregi.2023.04.007","article-title":"Anaphylactic reaction to praziquantel following schistosomiasis treatment","volume":"7","author":"Vasconcelos","year":"2023","journal-title":"IJID Reg"},{"key":"R19-20260302","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/9781119811794.ch16","article-title":"Nanotherapeutics of phytoantioxidants for parasitic diseases and neglected tropical diseases","author":"Zothantluanga","year":"2022","journal-title":"Phytoantioxidants Nanotherapeutics"},{"issue":"1","key":"R20-20260302","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijms24010787","article-title":"Nanoparticles in Clinical trials: Analysis of clinical trials, FDA approvals and use for COVID-19 vaccines","volume":"24","author":"Namiot","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R21-20260302","doi-asserted-by":"crossref","first-page":"e5898160","DOI":"10.1155\/2023\/5898160","article-title":"Nanoparticles: A potential and effective method to control insect-borne diseases","volume":"2023","author":"Nie","year":"2023","journal-title":"Bioinorg Chem Appl"},{"issue":"5","key":"R22-20260302","doi-asserted-by":"crossref","first-page":"NA","DOI":"10.1128\/AAC.02582-16","article-title":"Praziquantel for schistosomiasis: Single-drug metabolism revisited, mode of action, and resistance","volume":"61","author":"Vale","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"R23-20260302","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.3390\/pharmaceutics15102426","article-title":"Matrix-mediated delivery of silver nanoparticles for prevention of staphylococcus aureus and pseudomonas aeruginosa biofilm formation in chronic rhinosinusitis","volume":"15","author":"Yathavan","year":"2023","journal-title":"Pharmaceutics"},{"key":"R24-20260302","first-page":"4920209","article-title":"Nanotechnology-based approach in tuberculosis treatment","volume":"2017","author":"Nasiruddin","year":"2017","journal-title":"Tuberc Res Treat"},{"issue":"6","key":"R26-20260302","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/pathogens12060838","article-title":"Metallic nanoparticles and core-shell nanosystems in the treatment, diagnosis, and prevention of parasitic diseases","volume":"12","author":"Kr\u00f3l","year":"2023","journal-title":"Pathogens"},{"key":"R27-20260302","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jconrel.2023.10.050","article-title":"Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system","volume":"364","author":"Reus","year":"2023","journal-title":"J Control Release Off J Control Release Soc"},{"key":"R28-20260302","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fbioe.2020.00032","article-title":"A review of nanotechnology for targeted anti-schistosomal therapy","volume":"8","author":"Adekiya","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"6","key":"R29-20260302","doi-asserted-by":"crossref","first-page":"e0253522","DOI":"10.1128\/spectrum.02535-22","article-title":"Detection of antimalarial resistance-associated mutations in plasmodium falciparum via a platform of allele-specific pcr combined with a gold nanoparticle-based lateral flow assay","volume":"10","author":"Cheng","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"7","key":"R30-20260302","doi-asserted-by":"crossref","first-page":"284966","DOI":"10.1039\/C1CS15280G","article-title":"Gold nanoparticle-enabled biological and chemical detection and analysis","volume":"41","author":"Jans","year":"2012","journal-title":"Chem Soc Rev"},{"key":"R31-20260302","doi-asserted-by":"crossref","first-page":"106342","DOI":"10.1016\/j.actatropica.2022.106342","article-title":"A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni","volume":"229","author":"Ibrahim","year":"2022","journal-title":"Acta Trop"},{"issue":"9","key":"R32-20260302","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"R33-20260302","first-page":"1360","article-title":"Nanocarriers in tuberculosis treatment: Challenges and delivery strategies","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharm Basel Switz"},{"key":"R34-20260302","doi-asserted-by":"crossref","first-page":"121449","DOI":"10.1016\/j.carbpol.2023.121449","article-title":"Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis","volume":"323","author":"Primo","year":"2024","journal-title":"Carbohydr Polym"},{"key":"R35-20260302","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.actatropica.2017.06.025","article-title":"Nanotechnology as a potential therapeutic alternative for schistosomiasis","volume":"174","author":"Tomiotto-Pellissier","year":"2017","journal-title":"Acta Trop"},{"issue":"9","key":"R36-20260302","first-page":"S1555","article-title":"Formulation, optimization, and characterization of amlodipine besylate loaded polymeric nanoparticles","volume":"29","author":"Chourasiya","year":"2021","journal-title":"Polym Polym Compos"},{"issue":"1","key":"R37-20260302","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02652040400026285","article-title":"Praziquantel-loaded PLGA nanoparticles: preparation and characterization","volume":"22","author":"Mainardes","year":"2005","journal-title":"J Microencapsul"},{"issue":"3","key":"R38-20260302","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1166\/jbn.2018.2517","article-title":"Diagnosis, monitoring, and control of schistosomiasis-An update","volume":"14","author":"Wu","year":"2018","journal-title":"J Biomed Nanotechnol"},{"issue":"21","key":"R39-20260302","first-page":"3881","article-title":"Praziquantel-solid lipid nanoparticles produced by supercritical carbon dioxide extraction: physicochemical characterization, release profile, and cytotoxicity","volume":"24","author":"Andrade","year":"2019","journal-title":"Mol Basel Switz"},{"key":"R40-20260302","doi-asserted-by":"crossref","first-page":"108552","DOI":"10.1016\/j.exppara.2023.108552","article-title":"Loading praziquantel within solid lipid nanoparticles improved its schistosomicidal efficacy against the juvenile stage","volume":"251","author":"Mogahed","year":"2023","journal-title":"Exp Parasitol"},{"issue":"2","key":"R41-20260302","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/encyclopedia2020063","article-title":"Solid lipid nanoparticles","volume":"2","author":"Nguyen","year":"2022","journal-title":"Encyclopedia"},{"issue":"16","key":"R42-20260302","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.3390\/ijms23169485","article-title":"In Vivo Evaluation of praziquantel-loaded solid lipid nanoparticles against S. mansoni infection in preclinical murine models","volume":"23","author":"Adekiya","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R43-20260302","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.talanta.2019.05.111","article-title":"Label-free nanostructured biosensor for Schistosoma mansoni detection in complex biological fluids","volume":"204","author":"Santos","year":"2019","journal-title":"Talanta"},{"key":"R44-20260302","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2018.02.004","article-title":"The use of gold nanorods as a new vaccine platform against schistosomiasis","volume":"275","author":"Assis","year":"2018","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"1","key":"R45-20260302","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00436-021-07400-8","article-title":"Selenium and protozoan parasitic infections: selenocompounds and selenoproteins potential","volume":"121","author":"Rashidi","year":"2022","journal-title":"Parasitol Res"},{"issue":"9","key":"R46-20260302","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.3390\/ma16093382","article-title":"In Vitro release and in vivo pharmacokinetics of praziquantel loaded in different polymer particles","volume":"16","author":"Pereira","year":"2023","journal-title":"Materials"},{"issue":"3","key":"R47-20260302","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s40995-017-0150-z","article-title":"Albendazole and praziquantel chitosan nanoparticles: preparation, characterization, and in vitro release study","volume":"42","author":"Torabi","year":"2018","journal-title":"Iran J Sci Technol Trans Sci"},{"issue":"3","key":"R48-20260302","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.actatropica.2012.08.006","article-title":"Magnetic affinity enzyme-linked immunoassay based on recombinant 26 kDa glutathione-S-transferase for serological diagnosis of schistosomiasis japonica","volume":"124","author":"Yu","year":"2012","journal-title":"Acta Trop"},{"issue":"1","key":"R50-20260302","doi-asserted-by":"crossref","first-page":"e86578","DOI":"10.1371\/journal.pone.0086578","article-title":"PAMAMLys, a novel vaccine delivery vector, enhances the protective effects of the SjC23 DNA vaccine against Schistosoma japonicum infection","volume":"9","author":"Wang","year":"2014","journal-title":"PloS One"},{"issue":"10","key":"R51-20260302","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/bc800273j","article-title":"Nitrilotriacetic acid-derivatized quantum dots for simple purification and site-selective fluorescent labeling of active proteins in a single step","volume":"19","author":"Gupta","year":"2008","journal-title":"Bioconjug Chem"},{"issue":"1","key":"R52-20260302","article-title":"Praziquantel - chitosan nanoformulation against murine Schistosoma mansoni infection","volume":"113","author":"Tawfeek","year":"2020","journal-title":"QJM Int J Med"},{"issue":"1","key":"R53-20260302","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/10837450.2023.2169455","article-title":"Nanoparticle-based chewable gels of praziquantel","volume":"28","author":"Gonzalez","year":"2023","journal-title":"Pharm Dev Technol"},{"issue":"6","key":"R54-20260302","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4103\/njcp.njcp_1322_21","article-title":"Plant-derived compounds for the treatment of schistosomiasis: Improving efficacy via nano-drug delivery","volume":"25","author":"Eze","year":"2022","journal-title":"Niger J Clin Pract"},{"issue":"4","key":"R55-20260302","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1871526519666181231153139","article-title":"PZQ Therapy: How close are we in the development of effective alternative anti-schistosomal drugs?","volume":"19","author":"Aruleba","year":"2019","journal-title":"Infect Disord Drug Targets"},{"issue":"4","key":"R56-20260302","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","article-title":"Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems","volume":"10","author":"Mishra","year":"2018","journal-title":"Pharmaceutics"},{"issue":"3","key":"R57-20260302","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/pharmaceutics12030289","article-title":"Mechanochemical Formation of racemic praziquantel hemihydrate with improved biopharmaceutical properties","volume":"12","author":"Zanolla","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"R58-20260302","first-page":"513","article-title":"Infections associated with SARS-CoV-2 exploited via nanoformulated photodynamic therapy","volume":"11","author":"Pallavi","year":"2023","journal-title":"Admet Dmpk"},{"key":"R59-20260302","doi-asserted-by":"crossref","first-page":"100715","DOI":"10.1016\/j.curtheres.2023.100715","article-title":"Nanoparticles as potent agents for treatment of schistosoma infections: A systematic review","volume":"99","author":"Shakib","year":"2023","journal-title":"Curr Ther Res Clin Exp"},{"key":"R60-20260302","doi-asserted-by":"crossref","first-page":"168154","DOI":"10.1016\/j.scitotenv.2023.168154","article-title":"Electrochemical biosensing based comparative study of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein","volume":"908","author":"Drobysh","year":"2023","journal-title":"Sci Total Environ"},{"issue":"3","key":"R61-20260302","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"R62-20260302","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/life12111834","article-title":"In Vivo evaluation of the anti-schistosomal potential of ginger-loaded chitosan nanoparticles on schistosoma mansoni: Histopathological, ultrastructural, and immunological changes","volume":"12","author":"El-Derbawy","year":"2022","journal-title":"Life"},{"key":"R63-20260302","first-page":"191","article-title":"Nanoparticles against schistosomiasis","author":"Dkhil","year":"2016"},{"key":"R64-20260302","doi-asserted-by":"crossref","first-page":"124900","DOI":"10.1016\/j.talanta.2023.124900","article-title":"Emerging biomedical tools for biomarkers detection and diagnostics in schistosomiasis","volume":"265","author":"Lima","year":"2023","journal-title":"Talanta"},{"issue":"3","key":"R65-20260302","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nano9030474","article-title":"Application of Solid lipid nanoparticles to improve the efficiency of anticancer drugs","volume":"9","author":"Bayon-Cordero","year":"2019","journal-title":"Nanomater Basel Switz"},{"issue":"9","key":"R66-20260302","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/13543776.2021.1915292","article-title":"Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present)","volume":"31","author":"Adekiya","year":"2021","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"R67-20260302","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s42247-021-00168-8","article-title":"Nanomedicine for COVID-19: The role of nanotechnology in the treatment and diagnosis of COVID-19","volume":"4","author":"Vahedifard","year":"2021","journal-title":"Emergent Mater"},{"issue":"5","key":"R68-20260302","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s43588-023-00438-x","article-title":"Domain-agnostic predictions of nanoscale interactions in proteins and nanoparticles","volume":"3","author":"Saldinger","year":"2023","journal-title":"Nat Comput Sci"},{"key":"R69-20260302","doi-asserted-by":"crossref","first-page":"101784","DOI":"10.1016\/j.jddst.2020.101784","article-title":"Praziquantel-loaded solid lipid nanoparticles: Production, physicochemical characterization, release profile, cytotoxicity and in vitro activity against Schistosoma mansoni","volume":"58","author":"Andrade","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"R70-20260302","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s40824-023-00445-z","article-title":"Tumor-derived systems as novel biomedical tools-turning the enemy into an ally","volume":"27","author":"Desai","year":"2023","journal-title":"Biomater Res"},{"issue":"1","key":"R71-20260302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-023-15958-4","article-title":"Human and environmental impacts of nanoparticles: a scoping review of the current literature","volume":"23","author":"Kumah","year":"2023","journal-title":"BMC Public Health"},{"issue":"10","key":"R72-20260302","doi-asserted-by":"crossref","first-page":"237387","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: A review of fda-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm Res"},{"issue":"5","key":"R73-20260302","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2214-109X(22)00005-5","article-title":"The Lancet Global Health Commission on financing primary health care: putting people at the centre","volume":"10","author":"Hanson","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R74-20260302","first-page":"1","article-title":"Challenges and proven recommendations of praziquantel formulation","volume":"2023","author":"Kuevi","year":"2023","journal-title":"J Clin Pham Ther"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jvbd.jvbd_180_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:41:25Z","timestamp":1786650085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jvbd.jvbd_180_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jvbd.jvbd_180_23","relation":{"has-preprint":[{"id-type":"doi","id":"10.31219\/osf.io\/cynuw","asserted-by":"object"},{"id-type":"doi","id":"10.31219\/osf.io\/cynuw_v3","asserted-by":"object"},{"id-type":"doi","id":"10.31219\/osf.io\/cynuw_v2","asserted-by":"object"}]},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2023-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}